SEC Says It Charges TherapeuticsMD With Regulatory Violations; Says Co. Shared Material, Nonpublic Information With Sell-Side Research Analysts Without Disclosing The Information To The Public, Co. Has Agreed To Pay $200K Fine
Benzinga Newsdesk